Chairperson

Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals

Retrieved on: 
Tuesday, April 2, 2024

Bristol Myers Squibb (NYSE: BMY) today published its 2023 Environmental, Social, and Governance (ESG) Report detailing the company’s meaningful progress, evolved strategy, and aspirational goals toward its ESG efforts.

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) today published its 2023 Environmental, Social, and Governance (ESG) Report detailing the company’s meaningful progress, evolved strategy, and aspirational goals toward its ESG efforts.
  • The company’s ESG strategy is embedded in its mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
  • View the full release here: https://www.businesswire.com/news/home/20240402638203/en/
    “For more than 130 years, BMS has enabled positive change for our patients around the world.
  • Incorporated new ESG metrics into the executive compensation program, measuring achievement against environmental and social goals and better aligning executive bonuses with company strategy.

Avangrid Receives Federal Record of Decision for New England Wind

Retrieved on: 
Tuesday, April 2, 2024

New England Wind, consisting of the New England Wind 1 and New England Wind 2 projects, has the potential to create thousands of jobs and provide enough clean, reliable energy to power nearly 1 million homes and businesses in the region.

Key Points: 
  • New England Wind, consisting of the New England Wind 1 and New England Wind 2 projects, has the potential to create thousands of jobs and provide enough clean, reliable energy to power nearly 1 million homes and businesses in the region.
  • With this federal approval, New England Wind stands apart as the most advanced and shovel-ready offshore wind opportunity in the Northeast region.
  • “We applaud the Bureau of Ocean Energy Management for issuing the Record of Decision for New England Wind.
  • BOEM’s Record of Decision for Avangrid’s New England Wind lease area represents a key and substantial step in the direction of moving forward on offshore wind.

Allen Matkins Adds Real Estate Senior Counsel Jason Robinson to Growing New York Office

Retrieved on: 
Monday, April 1, 2024

Allen Matkins announced today that Jason Robinson has joined the firm as senior counsel in the New York office, where he will practice in the firm’s Real Estate Group.

Key Points: 
  • Allen Matkins announced today that Jason Robinson has joined the firm as senior counsel in the New York office, where he will practice in the firm’s Real Estate Group.
  • Jason was previously Deputy General Counsel at Bravo Capital and also spent time at several AmLaw firms in New York focusing on real estate transactions.
  • “We are excited to welcome Jason to the firm,” said Sandy Jacobson, Office Operating Partner of the New York Office and Co-Chair of Allen Matkins’ New York Real Estate Practice Group.
  • “With his experience working on complex leasing, financing, and acquisitions – Jason is an excellent addition to Allen Matkins’ real estate team.

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Retrieved on: 
Monday, April 1, 2024

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial.

Key Points: 
  • Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial.
  • Antibe expects to receive a formal Clinical Hold Letter from the FDA within 30 days outlining their rationale and further details.
  • Separately, the Company announced that Nuance Pharma Limited has commenced legal action in the Ontario Superior Court of Justice to seek recognition of and enforce the arbitration award in Ontario previously announced by Antibe in its press release of March 4, 2024.
  • Nuance Pharma is seeking the appointment of a receiver as part of its relief; a hearing date has not been set.

Terragia Secures $6M to Develop Cost-Competitive, Low-Carbon Biofuel Technology

Retrieved on: 
Thursday, March 28, 2024

Terragia Biofuel , a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP).

Key Points: 
  • Terragia Biofuel , a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP).
  • “Terragia has an exciting opportunity to succeed where others in the cellulosic biofuel industry have not.
  • Brief joins co-founders Lee Lynd, who transitioned to Chief Technology Officer, Bill Brady, Board Chair, and Chris Herring, Vice President of Technology Development.
  • We have a unique opportunity to make a transformational impact on climate outcomes, in addition to generating substantially higher revenues for biofuel producers.”

Getaround Reports Full Year 2023 Results

Retrieved on: 
Thursday, March 28, 2024

Getaround (NYSE: GETR) (“Getaround'' or “the Company”), the world’s first connected carsharing marketplace, today announced financial results for the year ended December 31, 2023.

Key Points: 
  • Getaround (NYSE: GETR) (“Getaround'' or “the Company”), the world’s first connected carsharing marketplace, today announced financial results for the year ended December 31, 2023.
  • Subsequently, in February 2024 the board appointed Eduardo Iniguez as Chief Executive Officer and board member of Getaround.
  • “With proper leadership, adequate funding and thoughtful capital allocation, we should be able to scale the platform Getaround built over the past decade exponentially.
  • “In December 2022, we deployed a new version of our Getaround TrustScore to improve the trust and safety of our marketplace.

Energous Corporation Reports 2023 Results

Retrieved on: 
Thursday, March 28, 2024

Energous Corporation (NASDAQ: WATT), a leading developer of RF-based charging for wireless power networks, today announced financial results for the year ended December 31, 2023, and provided an update on recent partnerships and company highlights.

Key Points: 
  • Energous Corporation (NASDAQ: WATT), a leading developer of RF-based charging for wireless power networks, today announced financial results for the year ended December 31, 2023, and provided an update on recent partnerships and company highlights.
  • Total costs and expenses were significantly reduced in 2023 from approximately $27.5 million in 2022 to approximately $22.6 million in 2023, representing a cost reduction of $4.9 million year over year.
  • Approximately $13.9 million in cash and cash equivalents at the end of 2023, with no debt.
  • Energous and Velociti — which deploys advanced enterprise technology solutions to some of the largest brands in the world, joined Energous as a preferred system integration partner and worldwide value-added reseller (VAR) for its technology.

Energous Announces Leadership Change

Retrieved on: 
Tuesday, March 26, 2024

Energous Corporation (NASDAQ: WATT), a leading developer of RF-based intelligent wireless power networks, today announced that Cesar Johnston is no longer serving in his role as President & CEO of Energous, effective immediately.

Key Points: 
  • Energous Corporation (NASDAQ: WATT), a leading developer of RF-based intelligent wireless power networks, today announced that Cesar Johnston is no longer serving in his role as President & CEO of Energous, effective immediately.
  • The Board of Directors has initiated a search to identify a permanent successor.
  • Reynette Au, Chair of the Board, stated: “On behalf of the full Board, I want to thank Cesar for his contributions to Energous, particularly for his work securing critical regulatory approvals for our WattUp wireless power transfer technology.
  • As previously announced, Energous will hold a conference call on Thursday, March 28, at 1:30 p.m. PT (4:30 p.m.

Li-Cycle Provides Organizational Structure Update

Retrieved on: 
Tuesday, March 26, 2024

Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery company, today provided a business update regarding its organizational structure.

Key Points: 
  • Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery company, today provided a business update regarding its organizational structure.
  • Ajay Kochhar, Li-Cycle President and CEO, commented: “We are recalibrating our organizational structure to better align with the more focused priorities of Li-Cycle.
  • Conor Spollen, who has been with Li-Cycle since January 2022, has assumed the role of Chief Operating Officer (COO).
  • These steps are expected to generate approximately $10 million in payroll and benefit cost savings on an annualized basis.

Dr. Jean Giddens from Virginia Commonwealth University Appointed Chair of the AACN Board of Directors

Retrieved on: 
Monday, March 25, 2024

The American Association of Colleges of Nursing (AACN) is pleased to announce that Jean Giddens, PhD, RN, FAAN, ANEF, dean and professor of nursing at the Virginia Commonwealth University, has been appointed Chair of the AACN Board of Directors.

Key Points: 
  • The American Association of Colleges of Nursing (AACN) is pleased to announce that Jean Giddens, PhD, RN, FAAN, ANEF, dean and professor of nursing at the Virginia Commonwealth University, has been appointed Chair of the AACN Board of Directors.
  • Dr. Giddens officially began her two-year term as Board Chair at noon today following AACN’s Spring 2024 Business Meeting in Washington, DC.
  • Her distinguished career in nurse education encompasses leadership roles at the University of New Mexico, Mesa State College, University of Texas-El Paso, and Eastern New Mexico University.
  • In addition, AACN’s President and Chief Executive Officer Deborah Trautman serves as an ex-officio member of the AACN Board.